Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in RXST — RxSight, Inc.

CIK 1167557 Greenwich, CT
Back to RXST Full portfolio

Position in RXST

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,393,039
+$3,474,490 QoQ
Shares Held
1,533,826
+141.1% QoQ
Ownership
3.69%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 151 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXST Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $3,270,437,578 across 82 Medical Devices names. RXST ranks #27 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BSX
Boston Scientific Corp
 9,681,750 $413,217,085
2 ABT
Abbott Laboratories
 4,193,058 $380,478,079
3 PODD
Insulet Corp
 2,455,135 $373,794,300
4 STE
STERIS plc
 1,377,297 $290,017,425
5 MDT
Medtronic plc
 3,299,627 $258,129,817
6 DXCM
Dexcom Inc
 3,237,720 $218,060,438
7 LIVN
LivaNova PLC
 2,356,191 $193,749,582
8 HAE
Haemonetics Corp
 2,266,489 $169,986,675

All Filings in RXST

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,393,039 1,533,826
2026-03-31 $3,918,549 636,129
2025-12-31 $1,032,828 99,120
2025-09-30 $234,069 26,037
2025-06-30 $835,900 64,300
2025-03-31 $967,250 38,307
2024-12-31 $1,724,191 50,151
2024-09-30 $3,024,917 61,196
2024-06-30 $3,528,006 58,634
2024-03-31 $2,060,414 39,946
2023-12-31 $454,124 11,263
2023-09-30 $223,287 8,006